Concordia Healthcare acquires legacy pharmaceutical products and acquires and develops orphan drugs.
Concordia is focused on acquiring Specialty Healthcare and Pharmaceutical Distribution companies.
Concordia Healthcare is listed on the TSX Exchange under (TSX:CXR).
March 19, 2015
– Fourth quarter 2014 revenue increase of 157 per cent compared to the fourth quarter of ...
March 17, 2015
TORONTO, ONTARIO–(March 17, 2015) - THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY ...